In situ cross-linkable hyaluronan for cartilage repair  by Aulin, C. et al.
Abstracts / Osteoarthritis and Cartilage 20 (2012) S10–S53S4061
LONG TERM FOLLOWUP OF FRESH OSTEOCHONDRAL
ALLOGRAFTING OF THE FEMORAL CONDYLE
Y. Levy 1,2, S. Görtz 3, P. Pulido 1, J. McCauley 1, W. Bugbee 4. 1 Shiley Ctr.
for Orthopaedic Res. & Ed. at Scripps Clinic, La Jolla, CA, USA; 2 Tel Aviv
Med. Ctr., Div. of Orthopaedic Surgery, Tel Aviv, Israel; 3Univ. of
California, San Diego Med. Ctr., san diego, CA, USA; 4 Scripps Clinic, Div.
of Orthopaedic Surgery, La Jolla, CA, USA
Background and purpuse: Articular cartilage injuries of the distal femur
are a challenging clinical entity. Fresh osteochondral allografting (OCA) is
an increasingly popular option for articular cartilage restoration. Many
short-term follow up studies demonstrate promising clinical results, but
there are few long-term follow up studies that provide information about
graft survivorship and durability. The purpose of this study was to assess
long-term clinical outcome, determine frequency and types of reopera-
tions, determine survivorship, and to evaluate predictors of OCA failure in
patientsundergoing freshOCAtransplantationdue tovariouspathologies.
Methods: Since 1983, our IRB-approved OCA outcomes program has
collected data on 614 OCA transplantation procedures of the knee
performed in 536 patients. Of those, we evaluated 122 patients (129
knees) who underwent OCA transplantation of the femoral condyle,
were at least ten years out from the index surgery and had a minimum
two-year followup. Mean age was 31.7 years (range, 15- 68 years); 85%
were younger than 45 years. 53% were male 47% were female. Diag-
noses included osteochondritis dissecans (45%), traumatic cartilage
injury (22.5%), degenerative chondral lesion (15.5%), avascular necrosis
(14.7%), and osteochondral fracture (2.3%). Average total graft area was
8.1 cm2 (range, 0.7-28.5 cm2). Clinical evaluation included the modiﬁed
D'Aubigne and Postel (18-point) scale, International Knee Documenta-
tion Committee (IKDC) pain and function scores, Knee Society (KS)
function scores and measures of subjective satisfaction. Reoperations
and failures were recorded. Graft failure was deﬁned as revision OCA, or
conversion to arthroplasty.
Results: Mean followup was 14.2 years (range, 2-27.5 years). Mean 18-
point score improved from 12.1 to 16.0, mean IKDC pain score improved
from 7.0 to 3.8, mean IKDC function score from 3.4 to 7.2, andmean KS-F
score from 65.6 to 82.5 (all, p<0.001), Subjectively, 97% of patients were
satisﬁed with their outcome. Sixty-one knees (47%) were re-operated.
Thirty knees (23%) had reoperations not necessarily related to the graft.
Thirty-one knees (24%) failed at a mean of 7.2  5.2 years (range, 1-19.7
years). Fifteen underwent revision OCA (48%) and 16 arthroplasty
conversions (52%). Kaplan Meier survivorship analysis showed survival
rates was 82% at ten, 74% at 15, and 66% at 20 years (ﬁgure 1). Logistic
regression analysis demonstrated that age 30 years at time of surgery
and having two or more previous surgeries in the operated knee were
associated with allograft failure.
Conclusion: Ostechondral allografting appears useful in treating wide
spectrum articular cartilage pathology. OCA resulted in durable improve-
ment in pain and function, with graft survivorship of 82% at 10 years.62
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Purpose: We have investigated the feasibility of an in situ cross-link-
able hyaluronan hydrogel system for cartilage repair in vitro and in vivo.
The hydrogel system is a two-component system based on aldehyde-
modiﬁed hyaluronic acid and hydrazide-modiﬁed polyvinyl alcohol,
which are rapidly cross-linked in situ upon mixing of the two polymer
components. The chemical modiﬁcation of this particular hyaluronan
formulation is low; approximately 5% of the carboxyl groups of the
backbone are modiﬁed.
Methods: Chondrocytes or mesenchymal stem cells were encapsulated
in the gel and cultured in chondrogenicmedium for 28 days. The in vitro
tissue formationwas analyzed by histology, immunohistochemistry and
dimethylmethylene blue assay for glucoseaminoglycan content. The in
vivo performance of the gel was studied as regeneration of local defects
in a rabbit model. A defect of 4 mm diameter was created on the medial
femoral condyle in the knee joints of 6 month old New Zealand White
rabbits. After assuring access to stem cells from subchondral bone by
bleeding, the patellawas relocated in position and the knee capsule was
tightly sutured before a volume of 0.4 ml of the hydrogel system was
injected into the knee joint. The same defect were created on the
contralateral knees, but was left untreated to serve as controls. The
animals were sacriﬁced after 3 or 6 months and the joints processed for
histopathological examination.
Results: We demonstrated that chondrocytes and mesenchymal cells
cultured in the hydrogel form cartilage-like tissue, rich in glucosami-
noglycans, collagen type II and aggrecan. In the rabbit animal model the
injection of the hydrogel improved the healing of full-thickness carti-
lage defect in the knee as compared to non-treated controls. The in vivo
study showed that the regenerated cartilage defects stained more
intense for type II collagen upon treatment with the hydrogel. Here and
in previous studies of bone regeneration using these materials, no
inﬂammatory response or capsule formation has been observed.
Conclusions: The results are very promising, and the hydrogel system
could be used both for cell based and cell free regeneration therapies.
Future studies are aimed to explore and develop a newway to contribute
to the repair of impaired bone and cartilage tissue in osteoarthritis. This
is based on the known facts that inﬂammatory stimuli as well as
mechanical load contributes to cartilage and bone damage in OA, and
that repair demands that the tissue should be supported with 1)
adequate biomechanical stimuli 2) suppress destructive inﬂammation
and 3) stimulate regeneration with anabolic factors. The hyaluronan
hydrogel systemwould provide the biomechanical support and ability to
deliver anti-inﬂammatory and anabolic factors to promote regeneration.
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THE CHONDROPROTECTIVE EFFECT OF FGF9 IN AN EXPERIMENT
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Purpose: To study the chondroprotective effect of local delivery of FGF9
in a rat meniscal tear model of osteoarthritis.
Methods: 34 skeletally mature male Lewis rats underwent surgery to
create full-thickness transection of the medial collateral ligament and
the medial meniscus of the right knee. Twoweeks after surgery animals
were randomized into two treatment groups: 18 animals received bi-
weekly intra-articular injections of 4 mg FGF9 in 50 ml saline for total of 3
weeks. A parallel treatment group included 16 animals that received
only 50 ml saline. Three days after the last injection, animals were
euthanized and 40 joints (6 normal, 16 surgery, 18 surgery + FGF9) were
processed and sections stained with toluidine blue. Quantitative and
semi-quantitative histopathological evaluationwas performed to assess
the osteoarthritic changes of the operated joints and the effect of FGF9
treatment in the medial tibial plateau region. The parameters that were
evaluated include: cartilage degeneration score, tibial cartilage degen-
eration width, cartilage thickness and depth of lesions, semi-quantita-
tive collagen damage assessment, percent proteoglycan loss, and
cartilage viability.
